Revlimid® Lawsuit Attorneys

What Happened: The Allegations Against Celgene

Revlimid has been one of the best-selling cancer drugs in the world, generating billions in annual revenue. According to multiple lawsuits — including federal antitrust litigation that has been working through the courts since 2014 — Celgene went to extraordinary lengths to protect that revenue at patients' expense:

• "Pay-for-delay" deals. Court filings allege Celgene paid generic drug manufacturers to delay launching affordable lenalidomide, settling patent lawsuits in exchange for agreements that kept competitors out of the market for years.
• Volume caps on generics. Even after generic versions began entering the market in 2022, lawsuits allege those generics were restricted by volume limits — agreements that kept supply artificially low and prices artificially high.
• A "patent thicket." Litigation alleges Celgene layered dozens of additional patents onto Revlimid, some covering uses well outside its original indications, to extend its monopoly and block competition for years longer than it otherwise could have.
• Use of a safety program as a shield. Some claims allege Celgene leveraged Revlimid's FDA-mandated safety program to make it harder for generic manufacturers to obtain the samples they needed to develop competing products.

The result, according to plaintiffs, ranging from health systems to union pension funds to individual patients: artificially inflated prices, constrained supply, and real people who couldn't get the medication they were prescribed to fight their cancer.

Why This Isn't Just a Pricing Dispute — It's a Patient Safety Issue

Most drug pricing controversies are about cost. This one is about access. When a multiple myeloma patient can't get their next round of Revlimid — because their pharmacy can't source it, because their insurer won't cover a price that's stayed artificially high, or because supply was capped by agreement rather than by manufacturing limits — the clock on their treatment doesn't stop. Cancer does not wait for litigation to resolve.

That's the heart of these claims: patients who relied on a prescribed treatment, only to have that treatment become unavailable or unaffordable because of decisions made in a boardroom, not a doctor's office.

Who May Qualify to File a Revlimid Claim

You may be eligible if your situation includes most or all of the following:

1. You Were Prescribed Revlimid or Lenalidomide

• For multiple myeloma or another qualifying condition
• Prescribed by your oncologist or treating physician

2. You Could Not Obtain the Medication

• Generic version was unavailable
• Brand-name drug was not covered by insurance
• Out-of-pocket cost was unaffordable
• Pharmacy could not fill the prescription

3. You Tried Every Available Option

• Applied for manufacturer assistance programs
• Sought foundation or grant funding
• Attempted pharmacy discount programs
• Appealed insurance denials

4. You Experienced a Treatment Gap

• Missed doses or a defined interruption in therapy
• No adequate substitute medication was available

5. Your Condition Worsened

• Disease progression
• Relapse or loss of remission
• Increased tumor burden
• Other measurable clinical harm

What Makes These Revlimid Cases Different?

Most patients are eventually able to obtain their prescribed Revlimid medication through insurance, assistance programs, or alternative pathways. Because of that, only a small number of cases may qualify.

Our focus is on situations where:

• Access was truly denied, not just delayed
• The interruption in treatment had a real medical impact
• There is clear documentation of both the denial and the worsened health conditions

What You’ll Need to Get Started

To evaluate your case, our team may request:

• Prescription records (dates, dosage, prescribing physician) 
• Insurance denials and appeals 
• Pharmacy records showing availability issues 
• Documentation of assistance program applications
• Medical records showing treatment interruption and outcome 

Frequently Asked Questions

What is Revlimid?

Revlimid is the brand name for lenalidomide, a prescription medication used to treat multiple myeloma, myelodysplastic syndromes, and certain forms of lymphoma.

Is this lawsuit about dangerous side effects?

Generally, these claims focus on allegations involving restricted access to Revlimid or generic lenalidomide rather than injuries caused by taking the medication itself.

Can I file a lawsuit if I eventually received the medication?

Possibly. Eligibility may depend on whether the delay caused a treatment interruption and whether that interruption contributed to measurable medical harm.

What if a loved one passed away after being unable to obtain Revlimid?

Surviving family members may have legal options, including wrongful death claims, depending on the circumstances.

How much does it cost to hire a Revlimid lawsuit attorney?

Most mass tort attorneys handle cases on a contingency fee basis, meaning there are no attorney fees unless compensation is recovered.

Why Patients Choose Hilliard Law

Going up against a global pharmaceutical company takes more than a phone call to a hotline — it takes a firm with the resources, the trial experience, and the resolve to see a fight through.

• A trial firm, not a settlement mill. Hilliard Law has built its reputation in courtrooms, not just negotiating rooms — including landmark verdicts like the $310 million judgment in the Tyre Sampson case and a $4.3 million jury award against Walmart.
• Decades of mass tort and pharmaceutical litigation experience. From Depo-Provera to talcum powder to PFAS contamination, Hilliard Law has represented patients and families going up against some of the largest companies in the world.
• A family firm with a national reach. Led by Robert C. Hilliard and built alongside his family and a deep bench of trial attorneys, the firm represents clients across Texas, Illinois, and nationwide.
• No upfront cost to you. Revlimid claims are handled on a contingency basis — you pay nothing unless and until Hilliard Law secures compensation on your behalf.

Start with a free, confidential case review by dialing (866) 927-3420 today*.

(* Submitting information does not guarantee a case. Due to the highly specific nature of these claims, only a limited number of inquiries will meet the criteria for legal action.)